Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review
Background Convalescent plasma and hyperimmune immunoglobulin may reduce mortality
in patients with viral respiratory diseases, and are currently being investigated in trials as …
in patients with viral respiratory diseases, and are currently being investigated in trials as …
[HTML][HTML] Rates among hospitalized patients with COVID-19 treated with convalescent plasma: a systematic review and meta-analysis
Objective To examine the association of COVID-19 convalescent plasma transfusion with
mortality and the differences between subgroups in hospitalized patients with COVID-19 …
mortality and the differences between subgroups in hospitalized patients with COVID-19 …
Convalescent plasma therapy for COVID-19: a systematic review and meta-analysis on randomized controlled trials
C Filippatos, I Ntanasis-Stathopoulos, K Sekeri… - Viruses, 2023 - mdpi.com
Background: While passive immunotherapy has been considered beneficial for patients with
severe respiratory viral infections, the treatment of COVID-19 cases with convalescent …
severe respiratory viral infections, the treatment of COVID-19 cases with convalescent …
Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis
Purpose To assess and compare the relative efficacy and safety of anti-SARS-CoV-2
antibody regimens for COVID-19. Methods This systematic review and random-effects …
antibody regimens for COVID-19. Methods This systematic review and random-effects …
Convalescent plasma and predictors of mortality among hospitalized COVID-19 patients: A systematic review and meta-analysis
M Franchini, M Cruciani, C Mengoli… - Clinical Microbiology …, 2024 - Elsevier
Background Plasma collected from recovered COVID-19 patients (COVID-19 convalescent
plasma, CCP) was the first antibody-based therapy employed to fight the COVID-19 …
plasma, CCP) was the first antibody-based therapy employed to fight the COVID-19 …
Convalescent plasma for people with COVID‐19: a living systematic review
C Iannizzi, KL Chai, V Piechotta… - Cochrane Database …, 2023 - cochranelibrary.com
Background Convalescent plasma may reduce mortality in patients with viral respiratory
diseases, and is being investigated as a potential therapy for coronavirus disease 2019 …
diseases, and is being investigated as a potential therapy for coronavirus disease 2019 …
The efficiency of convalescent plasma in COVID-19 patients: A systematic review and meta-analysis of randomized controlled clinical trials
Z Qian, Z Zhang, H Ma, S Shao, H Kang… - Frontiers in …, 2022 - frontiersin.org
The objective of this study was to assess whether convalescent plasma therapy could offer
survival advantages for patients with novel coronavirus disease 2019 (COVID-19). An …
survival advantages for patients with novel coronavirus disease 2019 (COVID-19). An …
Outcomes of convalescent plasma with defined high versus lower neutralizing antibody titers against SARS-CoV-2 among hospitalized patients: CoronaVirus …
LA Bartelt, AJ Markmann, B Nelson, J Keys, H Root… - MBio, 2022 - Am Soc Microbiol
ABSTRACT COVID-19 convalescent plasma (CCP) was an early and widely adopted
putative therapy for severe COVID-19. Results from randomized control trials and …
putative therapy for severe COVID-19. Results from randomized control trials and …
Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the …
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) arose in December 2019
in China rapidly evolving to the Coronavirus Disease 2019 (COVID-19) pandemic. Since …
in China rapidly evolving to the Coronavirus Disease 2019 (COVID-19) pandemic. Since …
Failed clinical trials on COVID-19 acute respiratory distress syndrome in hospitalized patients: common oversights and streamlining the development of clinically …
Introduction The coronavirus disease 2019 (COVID-19) pandemic has put a strain on global
healthcare systems. Despite admirable efforts to develop rapidly new pharmacotherapies …
healthcare systems. Despite admirable efforts to develop rapidly new pharmacotherapies …